Mission Bio
Read MoreMark S. Blumenkranz, CEO & Chairman
“I’ve had the fortunate opportunity to work closely with Mark Murray of FLG Partners in a series of four successful venture backed -backed companies in Silicon Valley over the past dozen years including Optimedica Corporation (acquired by Abbott), Oculeve (acquired by Allergan), Oyster Point Pharmaceuticals (IPO) and most recently Kedalion Therapeutics (acquired by Novartis)….Read More
Read More